Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US4788062A · kind A · utility
182Cited by
20References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 1987 |
| Grant date | Nov 29, 1988 |
| Priority date | — |
| Expiry date | Feb 26, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A transdermal delivery system for the administering of progesterone and an estradiol ester alone or in combination utilizing a polymer matrix having the drug(s) along with a permeation enhancer dispersed throughout.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.